Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
52.94
-0.01 (-0.02%)
At close: Apr 28, 2026, 4:00 PM EDT
52.93
-0.01 (-0.02%)
Pre-market: Apr 29, 2026, 4:45 AM EDT
Terns Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 6,112 | 4,394 | 471 | 401 | 504 | 179 | |
| Market Cap Growth | 3171.85% | 833.82% | 17.33% | -20.44% | 182.18% | - | |
| Enterprise Value | 5,094 | 4,100 | 99 | 135 | 318 | 1 | |
| Last Close Price | 52.94 | 40.40 | 5.54 | 6.49 | 10.18 | 7.07 | |
| PS Ratio | - | - | - | - | - | 178.64 | |
| PB Ratio | 5.91 | 4.37 | 1.36 | 1.57 | 1.82 | 1.11 | |
| P/TBV Ratio | 6.07 | 4.37 | 1.36 | 1.57 | 1.82 | 1.11 | |
| EV/Sales Ratio | - | - | - | - | - | 1.44 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.03 | -1.03 | -1.02 | -1.03 | |
| Net Debt / EBITDA Ratio | 9.25 | 9.25 | 3.51 | 2.57 | 4.58 | 3.36 | |
| Net Debt / FCF Ratio | 12.39 | 12.39 | 5.09 | 3.90 | 5.71 | 3.94 | |
| Asset Turnover | - | - | - | - | - | 0.01 | |
| Quick Ratio | 62.09 | 62.09 | 22.89 | 22.06 | 33.43 | 24.34 | |
| Current Ratio | 62.41 | 62.41 | 23.14 | 22.39 | 33.68 | 24.48 | |
| Return on Equity (ROE) | -14.23% | -14.23% | -29.56% | -33.89% | -27.60% | -43.83% | |
| Return on Assets (ROA) | -9.91% | -9.91% | -20.13% | -23.08% | -17.04% | -23.94% | |
| Return on Capital Employed (ROCE) | -10.90% | -10.90% | -29.20% | -40.00% | -22.30% | -30.90% | |
| Earnings Yield | -1.57% | -2.19% | -18.88% | -22.49% | -11.97% | -28.08% | |
| FCF Yield | -1.34% | -1.87% | -14.89% | -16.82% | -9.80% | -23.61% | |
| Buyback Yield / Dilution | -17.18% | -17.18% | -11.58% | -97.76% | -58.69% | -7862.47% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.